Brief: Chimerix Reports First Quarter 2023 Financial Results And Provides Operational Update

Chimerix

04/05/2023 12:21

Chimerix Inc  CMRX.O :
    * CHIMERIX REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES OPERATIONAL UPDATE
    * COMPLETION OF ONC206 DOSE ESCALATION EXPECTED BY FIRST
HALF 2024
    * EUROPEAN UNION STUDY AUTHORIZATION FOR PHASE 3 ACTION
RECEIVED,
REITERATE FIRST EFFICACY DATA EXPECTED EARLY 2025
    * QTRLY LOSS PER SHARE $0.24
    * Q1 EARNINGS PER SHARE VIEW $-0.25 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9ltFp6 
Further company coverage:  CMRX.O